FilingReader Intelligence
Joincare Pharmaceutical Group expands financing, restructures equity
April 7, 2025 at 05:14 PM UTC•By FilingReader AI
Joincare Pharmaceutical Group Industry (SSE:600380) has announced a series of strategic financial and structural decisions aimed at bolstering its growth and optimizing shareholder value. The company plans to seek credit financing of up to CNY 24.6 billion from various banks, while also addressing equity incentive plans and subsidiary ownership.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
Joincare Pharmaceutical Group Co., Ltd. 2024 Annual Report (English)April 7, 2025 at 11:20 AM UTC
Joincare Pharmaceutical Group Co., Ltd. 2024 Annual ReportApril 7, 2025 at 11:20 AM UTC
Verification report on the deposit and actual use of raised funds of Joincare Pharmaceutical Group Co., Ltd. in 2024April 7, 2025 at 11:20 AM UTC
Joincare Pharmaceutical Group Co., Ltd. 2024 Annual Audit ReportApril 7, 2025 at 11:20 AM UTC
Announcement of Kangyuan Pharmaceutical Group Co., Ltd. on the company's credit financing and financing guarantee for its subsidiariesApril 7, 2025 at 11:20 AM UTC
Announcement of Kangyuan Pharmaceutical Group Co., Ltd. on the guarantee provided by the company and its holding subsidiary Jiaozuo Kangyuan for the loan of Jinguan PowerApril 7, 2025 at 11:20 AM UTC
Announcement of Joincare Pharmaceutical Group Co., Ltd. on the Development of Foreign Exchange Derivatives Trading BusinessApril 7, 2025 at 11:20 AM UTC
Announcement of Kangyuan Pharmaceutical Group Co., Ltd. on the company's profit distribution plan for 2024April 7, 2025 at 11:20 AM UTC
Announcement of Kangyuan Pharmaceutical Group Co., Ltd. on the resignation of independent directors and the re-election of independent directorsApril 7, 2025 at 11:20 AM UTC
Announcement of Kangyuan Pharmaceutical Group Co., Ltd. on the capital increase and share expansion of its holding subsidiary Livzon BiopharmaceuticalsApril 7, 2025 at 11:20 AM UTC
Announcement of Kangyuan Pharmaceutical Group Co., Ltd. on the Development of Futures Hedging BusinessApril 7, 2025 at 11:20 AM UTC
SSE:600380•Shanghai Stock Exchange
News Alerts
Get instant email alerts when Joincare Pharmaceutical Group Industry publishes news
Free account required • Unsubscribe anytime